Filing Details
- Accession Number:
- 0001213900-18-007754
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-15 18:08:11
- Reporting Period:
- 2018-06-15
- Accepted Time:
- 2018-06-15 18:08:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1388320 | Actinium Pharmaceuticals Inc. | ATNM | Pharmaceutical Preparations (2834) | 880378336 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1615840 | Steve O'loughlin | C/O Actinium Pharmaceuticals, Inc 275 Madison Avenue, 7Th Floor New York NY 10016 | Principal Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-06-15 | 12,000 | $0.50 | 25,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
